Key result
Subjects with marked cardioinhibition during vasovagal syncope exhibited a larger and faster decrease in heart rate compared to those with intermediate and minimal cardioinhibition.
Why the study?
Hemodynamic parameters across different degrees of cardioinhibition during vasovagal syncope had not been directly compared.
How do hemodynamic parameters differ between subjects with marked, intermediate, and minimal cardioinhibition during vasovagal syncope?
Observational (n=149)
How do hemodynamic parameters differ between subjects with marked, intermediate, and minimal cardioinhibition during vasovagal syncope?
Marked cardioinhibition during vasovagal syncope is associated with distinct hemodynamic profiles, including higher baseline heart rates and a more rapid heart rate decline, which are present well before the onset of cardioinhibition.
Answers are grounded in this paper and cite their sources.
Hemodynamic differences by cardioinhibition severity may aid risk stratification; leaves open whether findings predict outcomes or guide therapy.
PURPOSE: We compared hemodynamic parameters between subjects with marked, intermediate and minimal cardioinhibition during vasovagal syncope. METHODS: The study included subjects with a decrease in heart rate while experiencing a complete vasovagal syncope during tilt-table testing. The subjects were classified as having marked, intermediate or minimal cardioinhibition, based on tertile values of the decrease in heart rate. Hemodynamic parameters between these groups were compared before tilt in the supine position, shortly after tilt and during cardioinhibition. RESULTS: A total of 149 subjects with a median age of 43 (interquartile range 24-60) years were included in the study. Among the three groups with different levels of cardioinhibition, the highest heart rate was observed in subjects with marked cardioinhibition both before and shortly after tilt and at the start of cardioinhibition. The heart rate decrease in these subjects was both larger and faster compared to subjects with minimal and intermediate cardioinhibition. CONCLUSION: Subjects with marked cardioinhibition have both a larger and faster decrease in heart rate compared to subjects with intermediate and minimal cardioinhibition, as early as from the start of cardioinhibition. Marked cardioinhibition is related to differences in hemodynamic profiles already present well before the start of cardioinhibition.
No takes yet. Share an insight, caveat, or question.
Rossum et al. (2023) conducted an observational in Vasovagal syncope (n=149). Marked cardioinhibition vs. Intermediate and minimal cardioinhibition was evaluated on Hemodynamic parameters including heart rate decrease. Subjects with marked cardioinhibition during vasovagal syncope exhibited a larger and faster decrease in heart rate compared to those with intermediate and minimal cardioinhibition.
Synapse has enriched 10 related papers. Consider them for comparative context: